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Summary
Background: Cardiac rehabilitation (CR) has numerous beneﬁcial effects, includ-
ing the modiﬁcation of coronary risk factors and improvement of the prognosis, in
patients with coronary artery disease (CAD). Limited data are available regarding
the effects of CR on the physical status and risk factors in patients with metabolic
syndrome (MetS) after coronary artery bypass grafting (CABG).
Methods and results: We enrolled 32 patients with MetS after CABG, who par-
ticipated in a supervised CR program for 6 months. Metabolic parameters, blood
chemistry, exercise tolerance, and muscle strength of the thigh were measured
before and after CR. After CR: (1) the body mass index, waist circumference, and
fat weight signiﬁcantly decreased; (2) peak V˙O2 and anaerobic threshold were sig-
niﬁcantly increased; (3) isokinetic peak torques of knee extensor and ﬂexor muscles
signiﬁcantly increased; (4) metabolic scoring deﬁned by the number of the modiﬁed
Adult Treatment Panel criteria of the US National Cholesterol Education Program
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was signiﬁcantly improved; (5) serum concentration of high-sensitivity C-reactive
protein also signiﬁcantly decreased.
Conclusions: These results suggest that CR might be useful for patients with MetS
after CABG.
e of Cardiology. Published by Elsevier Ireland Ltd. All rights
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We assessed body composition, exercise tolerance,
and muscle strength before and after CR. Anthro-© 2009 Japanese Colleg
reserved.
Metabolic syndrome (MetS), which is a cluster-
ing of cardiac risk factors caused by visceral fat
accumulation, is closely linked with the initiation
and progression of cardiovascular disease [1,2].
The accumulation of visceral fat is essential for
the diagnosis of the MetS, which is considered to
locate upstream of multiple risk factors [3]. The
main concept of the MetS is to recognize the effec-
tive reduction of multiple coronary risk factors and
subsequent cardiovascular diseases by the reduc-
tion of visceral fat [3]. Recently, much attention
has focused on the relationship of inﬂammation
in adipose tissue with the pathogenesis of MetS
and atherosclerotic diseases [2—5]. It is clear that
cardiac rehabilitation (CR) has numerous bene-
ﬁts involving not only modulating risk factors, but
also preventing future cardiac events [6,7]. How-
ever, the impact of CR on metabolic parameters
in patients with MetS after coronary artery bypass
grafting (CABG) is still unclear. The purpose of the
present study was to investigate the clinical useful-
ness of CR, including the improvement of metabolic
risk factors and the inﬂammatory state, in patients
with MetS after CABG.
Methods
Subjects
We enrolled 32 patients with MetS, deﬁned by
the modiﬁed Adult Treatment Panel criteria of the
US National Cholesterol Education Program (waist
size: male ≥85 cm and female ≥90 cm) after CABG
at Juntendo University Hospital. All patients par-
ticipated in CR after CABG (5—14 days). Patients
with ongoing congestive heart failure, liver dys-
function, renal failure (creatinine ≥2.0mg/dL),
or systemic diseases, including malignancy and
collagen disease, were excluded. All patients
received anti-platelet therapy. The subjects took
the following medications: calcium-channel block-
ers, n = 18; beta-blockers, n = 13; angiotensin-
converting enzyme inhibitors or angiotensin II
receptor blockers, n = 15; statins, n = 14; oral
hypoglycemic agents, n = 8 and insulin, n = 5.
p
m
c
m
Co subjects underwent a change of medication
hroughout the study period except for three
atients newly treated with statins. Subjects
eceived full verbal and written explanations of the
ature and purposes of the study, and each gave
ritten informed consent. This study was approved
y the Ethical Committee of Juntendo University.
ehabilitation protocol
upervised CR, which was composed of warm-up
tretching, aerobic exercise, resistance training,
nd cool-down stretching, was performed once or
wice a week for 6 months, as we described pre-
iously [8,9]. Aerobic exercise consisted of a cycle
rgometer, treadmill, and walking on an in-room
rack. The total aerobic exercise time was approx-
mately 60min. The exercise intensity was pre-
cribed individually at the anaerobic threshold (AT)
evel, as measured by an ergometer test using expi-
atory gas analysis or a rating of 11—13 (from fairly
ight to somewhat hard) on the standard Borg’s per-
eived exertion scale. Resistance training, which
as gradually added to the exercise program at
east 6 weeks after the beginning of participation,
onsisted of four types of training (sit-ups, back
icks and front raises, squats and push-ups) using
he patients’ own weight. In addition, patients
ere encouraged to perform home-based aerobic
xercise for more than 20min at a rating of 11—13
f the perceived exertion on Borg’s scale twice a
eek. All subjects were instructed to follow the
hase II diet of the American Heart Association after
ABG at the beginning. An educational program
as also provided for each subject by physicians,
urses, and dietitians regarding ischemic heart dis-
ase and risk factors at the baseline.
easurementsometric parameters were assessed using the body
ass index (BMI) and waist circumference. The per-
entages of body fat and lean body weight were
easured by a BOD POD® (Life Measurement, Inc.,
oncord, CA, USA), as we described previously
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Table 1 Baseline characteristics.
N 32
Age (year) 66± 10
Male (%) 29 (97)
Body mass index (kgm−2) 25.0± 2.7
Hypertension (%) 30 (94)
Diabetes mellitus (%) 20 (63)
Dyslipidemia (%) 23 (77)
% fat 28.7± 5.5
Off pump (%) 30 (94)
Number of bypass grafting (n) 3.4± 1.3
b
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icantly increased after CR (from 149± 41 to
169± 47Nm·kg−1 × 100, p < 0.001, and 85± 28 to
98± 30Nm·kg−1 × 100, p < 0.001, respectively).
Table 2 Physiological variables.
Pre Post p
Waist (cm) 87.1 ± 8.5 84.0 ± 6.9 <0.001ardiac rehabilitation in MetS after CABG
8,9]. To measure peak oxygen consumption (peak
˙O2) and the AT, patients underwent ergometer
esting (Corival 400, Lode B.V. Groningen, Nether-
ands) using an expiratory gas analysis machine
Vmax-29S, SensorMedics Co., Yorba Linda, CA,
SA). After a period of resting, warm-up was per-
ormed for a few minutes at 20W, followed by
amp loading (15W/min) until subjective exhaus-
ion, progressive angina, ST-segment depression
≥2mm), or sustained tachyarrhythmia. The point
f AT was determined by the ‘V-slope’ method.
he power of the thigh muscles was measured
sing the Cybex770 system (Cybex Division of
umex, Ronkonkoma, NY, USA), as we reported
reviously [8,9]. The isokinetic peak torques of
he knee extensor and ﬂexor muscles were mea-
ured at 60◦/s, and those were adjusted by body
eight according to the following formula: strength
Nm)× 100/body weight (kg). Serum lipid proﬁles,
ncluding total cholesterol (TC), triglycerides (TG),
nd high-density lipoprotein cholesterol (HDL-C),
nd high-sensitivity C-reactive protein (hsCRP)
ere determined by standard methods using an
uto-analyzer after at least 12 h of fasting before
nd 6 months after CABG. Concentrations of
ow-density lipoprotein cholesterol (LDL-C) were
alculated with the Friedewald equation using the
oncentrations of TC, HDL-C, and TG.
eﬁnition of MetS score
n the present study, the MetS score (from 0 to
) was deﬁned by the number of criteria of the
odiﬁed Adult Treatment Panel criteria of the
ational Cholesterol Education Program. Each cri-
erion, excluding waist size (male ≥85 cm and
emale ≥90 cm), was utilized following the original
eﬁnition [10].
tatistical analysis
he results are expressed as the mean
alue± standard deviation. Data at the base-
ine and after 6 months were compared in each
atient by the paired t-test. A p-value of less than
.05 was considered signiﬁcant.
esultsaseline characteristics
he baseline characteristics of the subjects are pre-
ented in Table 1. The prevalence of hypertension,
iabetes, and dyslipidemia, was relatively high,Exercise in hospital (times) 34± 12
Data are presented as the mean value± S.D.
ecause this study consisted of patients with MetS.
inety-four percent of the subjects underwent an
ff-pump operation, and the mean number of times
erforming CR was 34.
arameters after CR for 6 months
hysiological variables
hysiological variables at the baseline and after
R are presented in Table 2. After CR, waist size
from 87.1± 8.5 to 84.0± 6.9 cm, p < 0.01), body
eight (from 65.4± 9.5 to 63.5± 8.4 kg, p < 0.01),
at weight (from 18.5± 5.1 to 17.2± 4.7 kg,
< 0.05), and % fat (from 28.7± 5.5 to 26.8± 6.0%,
< 0.01) were signiﬁcantly decreased and the lean
ody weight was increased (from 45.6± 6.9 to
6.5± 6.7 kg, p < 0.005).
xercise tolerance and strength of thigh muscles
xercise tolerance and the strength of the thigh
uscles at the baseline and after CR are presented
n Figs. 1 and 2, respectively. Peak V˙O2 and AT sig-
iﬁcantly increased after CR (from 14.2± 3.7 to
9.2± 5.2ml·kg−1·min−1), p < 0.001, and 8.8± 1.9
o 11.5± 3.1ml·kg−1·min−1, p < 0.001, respec-
ively). The isokinetic peak torques of the
nee extensor and ﬂexor muscles were signif-Weight (kg) 65.4 ± 9.5 63.5 ± 8.4 0.0005
Fat weight (kg) 18.5 ± 5.1 17.2 ± 4.7 0.019
Lean weight (kg) 45.6 ± 6.9 46.5 ± 6.7 0.003
% fat 28.7 ± 5.5 26.8 ± 6.0 0.008
384 T. Onishi et al.
Figure 1 Left: change of peak V˙O2 (oxygen uptake) between pre- and post-training. Right: AT (anaerobic threshold)
between pre- and post-training.
Figure 2 Left: change of knee extension between pre- an
post-training.
Serum lipid proﬁles, glucose parameters, and
blood pressure
Serum lipid proﬁles, glucose parameters, and blood
pressure at the baseline and after CR are pre-
sented in Table 3. Serum concentrations of TC
Table 3 Clinical variables pre- and post-cardiac
rehabilitation.
Pre Post p
TC (mg/dL) 199 ± 34 182 ± 28 0.008
LDL-C (mg/dL) 122 ± 29 111 ± 22 0.047
TG (mg/dL) 174 ± 74 139 ± 66 0.060
HDL-C (mg/dL) 43 ± 13 44 ± 11 0.602
FBS (mg/dL) 135 ± 45 131 ± 50 0.420
HbA1c (%) 6.2 ± 1.3 6.2 ± 1.3 0.613
SBP (mmHg) 140 ± 16 134 ± 19 0.143
DBP (mmHg) 76 ± 11 76 ± 8 0.897
Data are presented as the mean value± S.D. TC, total
cholesterol; LDL-C, low-density lipoprotein cholesterol; TG,
triglycerides; HDL-C, high-density lipoprotein cholesterol;
FBS, fasting blood sugar; HbA1c, hemoglobin A1c; SBP, sys-
tolic blood pressure; DBP, diastolic blood pressure.
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ad post-training. Right: knee ﬂexion between pre- and
nd LDL-C were signiﬁcantly decreased after CR
from 199± 34 to 182± 28mg/dL, p < 0.01 and from
22± 29 to 111± 22mg/dL, p < 0.05, respectively).
owever, no signiﬁcant changes were observed in
ther values.
erum levels of hsCRP
erum levels of hsCRP were signiﬁcantly decreased
fter CR (from 0.30± 0.21 to 0.25± 0.29mg/dL,
< 0.001) (Fig. 3). A signiﬁcant decrease was also
bserved after the exclusion of three patients who
ere newly prescribed statins after CABG (from
.27± 0.19 to 0.19± 0.18mg/dL, p < 0.005).
etS score
he MetS score was signiﬁcantly decreased after CR
from 3.6± 0.7 to 2.4± 1.0, p < 0.001) (Fig. 4).iscussion
he present study showed that CR for 6 months
meliorated not only metabolic parameters, but
Cardiac rehabilitation in MetS after CABG
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wigure 3 Change of CRP (C-reactive protein) between
re- and post-training.
lso the exercise capacity, muscle strength, and
nﬂammatory state in MetS patients after CABG.
The prevalence of MetS, closely linked to the ini-
iation and progression of cardiovascular diseases,
as markedly increased in not only developed coun-
ries, but also developing nations [11,12]. Indeed,
e and other groups reported the impact of MetS on
linical outcomes in patients with coronary artery
isease [11—13]. Although it has been elucidated
hat exercise decreases the prevalence of MetS
14—16], the beneﬁcial effects of CR in patients
ith MetS, especially after CABG are still unclear.
ilani and Lavie [17,18] reported that CR improved
ultiple metabolic derangements, however, the
ubjects consisted of patients with various diag-
oses after major cardiac events. Shubair et al. [19]
howed that CR resulted in a signiﬁcant improve-
ent in the cardiovascular risk proﬁles, including
ody weight, lipid proﬁle, blood glucose, and exer-
ise capacity, however, this study also consisted of
atients with various diagnoses of coronary artery
isease. Patients who need to undergo CABG show
igure 4 Change of MetS (metabolic syndrome) score
etween pre- and post-training.
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high risk based on clinical ﬁndings, such as multi-
essel disease and diabetes [20]. It is clear that
hese clinical manifestations are associated with
poor outcome in the clinical setting [21,22].
herefore, it is very important to investigate the
fﬁcacy of CR for improving metabolic parameters
n patients after CABG.
It has been clearly established that exercise
olerance is a good predictor of the prognosis in
atients with cardiovascular diseases [23,24]. In
ddition, muscular strength is also associated with
ll-cause mortality [25]. A report from the WHO
uggested that increased muscle strength results in
n improved long-term prognosis [26]. The present
tudy did not include non-participating patients.
t is possible that exercise tolerance might be
mproved by not only the natural course after CABG,
ut also the effect of CR. Indeed, Perk and Hedback
eported that patients participating in CR following
ABG showed a greater increase in work capacity
nd a more favorable effect on myocardial oxy-
en consumption compared with non-participating
atients [27,28]. Our recent study also demon-
trated that muscle strength of the lower limbs
id not change in non-participating patients with
oronary artery disease, including post CABG [9].
herefore, we believe that CR, at least partly,
rought about the amelioration of exercise tol-
rance and muscular strength, and may be an
mportant strategy in patients with MetS after
ABG.
Chronic inﬂammation plays an important role
n the initiation and progression of atherosclero-
is [2,5,29,30]. Indeed, circulating levels of hsCRP,
hich is one of the acute phase-reactant proteins
n inﬂammatory reactions, are elevated in patients
ith coronary heart diseases [26,29]. Moreover,
igh levels of hsCRP can predict mortality and
uture cardiac events in various patients with car-
iovascular diseases [31]. Some previous studies
ave reported the improvement of hsCRP eleva-
ion in participants with CR [32,33]. The result of
sCRP reduction in patients with CR after CABG is
onsistent with previous results. No reports have
nvestigated the changes of hsCRP comparing CR
nd non-CR groups in patients after CABG. Pre-
ious studies showed that the levels of hsCRP
emained unchanged in the control group after per-
utaneous coronary intervention [34,35]. Eyileten
t al. reported that hsCRP levels signiﬁcantly
ecreased 1 month after CABG. However, the sub-
ects in their study must be different from those
f the present study. Because the mean levels of
sCRP in Eyileten’s study were relatively high (from
.315± 0.240 to 0.725± 0.189mg/dL), suggesting
hat subjects who had ongoing acute inﬂammation
R[
[
[386
were included [36]. Moreover, the levels of hsCRP
at the baseline were signiﬁcantly higher in patients
with than in those without MetS after CABG (data
not shown), suggesting that CR is a useful strat-
egy to improve the inﬂammatory state even in MetS
patients after CABG.
Limitations
There are several limitations to the present study.
First, this is a small sample-sized study. Second,
the supervised exercise in the outpatient clinic was
performed only once or twice a week. Therefore,
the protocol of the present study might not be
sufﬁcient to improve the metabolic status, such
as TG and HDL-C levels. Third, the present study
consisted of only subjects who participated in CR
after CABG. We assessed the levels of serum lipids
and hsCRP in 14 patients (12 males, 66± 8 years)
with MetS, who did not participate in supervised CR
after elective CABG in the outpatient clinic because
of difﬁculty undergoing CR (a long distance from
home to hospital) during the same period. Before
and 6 months after CABG, no signiﬁcant changes
in TC (from 189± 26 to 208± 37mg/dL, p = 0.11),
LDL-C (from 112± 23 to 125± 34mg/dL, p = 0.25),
TG (from 214± 72 to 212± 97mg/dL, p = 0.93),
or hsCRP (from 0.22± 0.13 to 0.26± 0.22mg/dL,
p = 0.51) were observed. The results of this study
need to be conﬁrmed using a prospective and
randomized study design involving patients par-
ticipating and not participating in CR. However,
we believe that the present study is a pioneering
and valuable report promoting further investiga-
tions.
Conclusion
CR might have effects on not only the modiﬁcation
of metabolic risk factors, but also improving exer-
cise tolerance and muscular strength in patients
with MetS after CABG. Further studies with a con-
trol group are required to conﬁrm these ﬁndings
and to assess the efﬁcacy of CR for improv-
ing the clinical prognosis in MetS patients after
CABG.
AcknowledgmentsThis work was partially supported by High Tech-
nology Research Center Grant from the Ministry of
Education, Culture, Sports, Science and Technology
of Japan. The authors wish to thank each of the
participants for providing data.
[T. Onishi et al.
eferences
[1] Nakamura T, Tokunaga K, Shimomura I, Nishida M, Yoshida
S, Kotani K, Waliul Islam AHM, Keno Y, Kobatake T, Nagai Y,
Fujioka S, Tarui S, Matsuzawa Y. Contribution of visceral fat
accumulation to the development of coronary artery dis-
ease in non-obese men. Atherosclerosis 1994;107:239—46.
[2] Fernandez-Real JP, Ricart W. Insulin resistance and
chronic cardiovascular inﬂammatory syndrome. Endocr Rev
2003;24:278—301.
[3] Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shi-
mamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote
K, Yokode M. Metabolic syndrome. J Atheroscler Thromb
2008;15:1—5.
[4] Matsuzawa Y, Shimomura I, Kihara S, Funahashi T. Impor-
tance of adipocytokines in obesity-related disease. Horm
Res 2003;60(Suppl. 3):56—9.
[5] Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe
K. Adiponectin and adiponectin receptors in insulin resis-
tance, diabetes, and the metabolic syndrome. J Clin Invest
2006;116:1784—92.
[6] Lavie CJ, Milani RV, Littman AB. Beneﬁts of cardiac reha-
bilitation and exercise training in secondary coronary
prevention in elderly. J Am Coll Cardiol 1993;22:678—83.
[7] Williams MA, Fleg JL, Ades PA, Chaitman BR, Miller NH,
Mohiuddin SM, Ockene IS, Taylor CB, Wenger NK. American
Heart Association Council on Clinical Cardiology Subcom-
mittee on Exercise, Cardiac Rehabilitation, and Prevention.
Secondary prevention of coronary heart disease in the
elderly (with emphasis on patients ≥75 years of age):
an American Heart Association Scientiﬁc Statement from
the Council on Clinical Cardiology Subcommittee on Exer-
cise, Cardiac rehabilitation, and Prevention. Circulation
2002;105:1735—43.
[8] Seki E, Watanabe Y, Sunayama S, Iwama Y, Shimada K,
Kawakami K, Sato M, Sato H, Mokuno H, Daida H. Effects of
phase III cardiac rehabilitation programs on health-related
quality of life in elderly patients with coronary artery dis-
ease: Juntendo Cardiac Rehabilitation Program (J-CARP).
Circ J 2003;67:73—7.
[9] Seki E, Watanabe Y, Shimada K, Sunayama S, Onishi T,
Kawakami K, Sato M, Sato H, Mokuno H, Daida H. Effects of
a phase III cardiac rehabilitation program on physical sta-
tus and lipid proﬁles in elderly patients with coronary artery
disease: Juntendo cardiac rehabilitation program (J-CARP).
Circ J 2008;72:1230—4.
10] National Cholesterol Education Program (NCEP) Expert
Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults (Adult Treatment Panel III).
Third Report of the National Cholesterol Education Program
(NCEP) Expert Panel on Detection, Evaluation, and Treat-
ment of High Blood Cholesterol in Adults (Adult Treatment
Panel III). Final Report. Circulation 2002;106:3143—421.
11] Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo
E, Tumilehto J, Salonen JT. The metabolic syndrome and
total and cardiovascular disease mortality in middle-aged
men. JAMA 2002;228:2709—16.
12] Ramachandran A, Snehalatha C, Latha E, Manoharan M,
Vijay V. Impacts of urbanization on the prevalence of dia-
betes in native Asian Indian population. Diabetes Res Clin
Pract 1999;44:207—13.13] Kasai T, Miyauchi K, Kurata T, Ohta H, Okazaki S, Miyazaki
T, Kajimoto K, Kubota N, Daida H. Prognostic value of the
metabolic syndrome for long-term outcomes in patients
undergoing percutaneous coronary intervention. Circ J
2006;70:1531—7.
C[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[ardiac rehabilitation in MetS after CABG
14] Blair SN, Church TS. The ﬁtness, obesity, and health
equation. Is activity the common demominator? JAMA
2004;292:1232—3.
15] Lavie CJ, Milani RV. Metabolic syndrome, inﬂammation, and
exercise. Am J Cardiol 2004;93:1334.
16] Savage PD, Banzer JA, Balady GJ, Ades PA. Prevalence
of metabolic syndrome in cardiac rehabilitation/secondary
prevention programs. Am Heart J 2005;149:627—31.
17] Milani RV, Lavie CJ. Prevalence and proﬁle of metabolic
syndrome in patients following acute coronary events and
effects of therapeutic lifestyle change with cardiac reha-
bilitation. Am J Cardiol 2003;92:50—4.
18] Lavie CJ, Milani RV. Cardiac rehabilitation and exercise
training programs in metabolic syndrome and diabetes. J
Cardiopulm Rehabil 2005;25:59—66.
19] Shubair MM, Kodis J, McKelvie RS, Arthur HM, Sharma AM.
Metabolic proﬁle and exercise capacity outcomes. J Car-
diopulm Rehabil 2004;24:405—13.
20] The bypass angioplasty revascularization investigation
(BARI) investigators. Comparison of coronary bypass surgery
with angioplasty in patients with multivessel disease. N Engl
J Med 1996;335:217—25.
21] Malenka DJ, Leavitt BJ, Hearne MJ, Robb JF, Baribeau YR,
Ryan TJ, Helm RE, Kellett MA, Dauerman HL, Dacey LJ, Sil-
ver MT, VerLee PN, Weldner PW, Hettleman BD, Olmstead
EM, et al. Comparing long-term survival of patients with
multivessel coronary disease after CABG or PCI: analysis
of BARI-like patients in northern New England. Circulation
2005;112(Suppl.):I371—6.
22] Flaherty JD, Davidson CJ. Diabetes and coronary revascu-
larization. JAMA 2005;293:1501—8.
23] Belardinelli R, Georgiou D, Cianci G, Purcaro A. Ran-
domized, controlled trial of long-term moderate exercise
training in chronic heart failure: effects on functional
capacity, quality of life, and clinical outcome. Circulation
1999;99:1173—82.
24] Chua TP, Poinkowski P, Harrington D, Anker SD, Webb-
peploe K, Clark AL, Poole-Wilson PA, Coats AJ. Clinical
correlates and prognostic signiﬁcance of the ventilatory
response to exercise in chronic heart failure. J Am Coll
Cardiol 1997;29:1585—90.
25] Braith RW, Stewart KJ. Resistance exercise training: its
role in the prevention of cardiovascular disease. Circulation
2006;113:2642—50.
[
Available online at www.s387
26] WHO Expert Committee. Physical status: the use and inter-
pretation of anthropometry. WHO TRS 1995;854:375—409.
27] Perk J, Hedbäck B, Engvall J. Effects of cardiac rehabilita-
tion after coronary artery bypass grafting on readmissions,
return to work, and physical ﬁtness: a case—control study.
Scand J Soc Med 1990;18:45—51.
28] Hedbäck BE, Perk J, Engvall J, Areskog NH. Cardiac reha-
bilitation after coronary artery bypass grafting: effects on
exercise performance and risk factors. Arch Phys Med Reha-
bil 1990;71:1069—73.
29] Yoshikane H, Yamamoto T, Ozaki M, Matsuzaki M. Clin-
ical signiﬁcance of high-sensitivity C-reactive protein in
lifestyle-related disease and metabolic syndrome. J Cardiol
2007;50:175—82.
30] Yamashita H, Shimada K, Seki E, Mokuno H, Daida H.
Concentrations of interleukins, interferon, and C-reactive
protein in stable and unstable angina pectoris. Am J Cardiol
2003;91:133—6.
31] Ridker PM. Inﬂammatory biomarkers and risks of myocardial
infraction, stroke, diabetes, and total mortality: implica-
tions for longevity. Nutr Rev 2007;65:S253—9.
32] Goldhammer E, Tanchilevitch A, Maori I, Beniamini Y, Rosen-
schein U, Sagav M. Exercise training modulates cytokines
activity in coronary heart disease patients. Int J Cardiol
2005;100:93—9.
33] Caulin-Glaser T, Falko J, Hindman L, Londe LM, Snow R.
Cardiac rehabilitation is associated with an improvement in
C-reactive protein levels in both men and women with car-
diovascular disease. J Cardiopulm Rehabil 2005;25:332—6.
34] Walther C, Mobius-Winkler S, Linke A, Bruegel M, Thiery J,
Schuler G, Halbrecht R. Regular exercise training compared
with percutaneous intervention leads to a reduction of
inﬂammatory markers and cardiovascular events in patients
with coronary artery disease. Eur J Cardiovasc Prev Rehabil
2008;15:107—12.
35] Kim YJ, Shin YO, Bae JS, Lee JB, Ham JH, Son YJ, Kim JK,
Kim C, Lee BK, Oh JK, Othman T, Min YK, Yang HM. Beneﬁcial
effects of cardiac rehabilitation and exercise after percu-
taneous coronary intervention on hsCPR and inﬂammatory
cytokines in CAD patients. Pﬂug Arch 2008;455:1081—8.
36] Eyileten Z, Yilmaz MI, Kaya K, Akar AR, Kahraman D, Bingol
S, Uysalel A, Ozyurda U. Coronary artery bypass graft-
ing ameliorates the decreased plasma adiponectin level in
atherosclerotic patients. Tohoku J Exp Med 2007;213:71—7.
ciencedirect.com
